ADE
MCID: ACT049
MIFTS: 50

Acute Disseminated Encephalomyelitis (ADE)

Categories: Eye diseases, Infectious diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Acute Disseminated Encephalomyelitis

MalaCards integrated aliases for Acute Disseminated Encephalomyelitis:

Name: Acute Disseminated Encephalomyelitis 12 53 54 59 15 17
Acute Disseminated Encephalitis 12 59 72 33
Adem 12 53 59
Encephalomyelitis, Acute Disseminated 72
Encephalomyelitis Acute Disseminated 55
Ade 53

Characteristics:

Orphanet epidemiological data:

59
acute disseminated encephalomyelitis
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Europe); Age of onset: All ages; Age of death: normal life expectancy;

Classifications:



External Ids:

Disease Ontology 12 DOID:639
MeSH 44 D004673
NCIt 50 C34578
SNOMED-CT 68 83942000
ICD10 33 G04.0
ICD10 via Orphanet 34 G04.0
UMLS via Orphanet 73 C0014059
Orphanet 59 ORPHA83597
UMLS 72 C0014059 C3536864

Summaries for Acute Disseminated Encephalomyelitis

NINDS : 54 Acute disseminated encephalomyelitis (ADEM) is characterized by a brief but widespread attack of inflammation in the brain and spinal cord that damages myelin – the protective covering of nerve fibers.  ADEM often follows viral or bacterial infections, or less often, vaccination for measles, mumps, or rubella.  The symptoms of ADEM appear rapidly, beginning with encephalitis-like symptoms such as fever, fatigue, headache, nausea and vomiting, and in the most severe cases, seizures and coma.  ADEM typically damages white matter (brain tissue that takes its name from the white color of myelin), leading to neurological symptoms such as visual loss (due to inflammation of the optic nerve) in one or both eyes, weakness even to the point of paralysis, and difficulty coordinating voluntary muscle movements (such as those used in walking).  ADEM is sometimes misdiagnosed as a severe first attack of multiple sclerosis (MS), since the symptoms and the appearance of the white matter injury on brain imaging may be similar.  However, ADEM has several features which differentiate it from MS.  First, unlike MS patients, persons with ADEM will have rapid onset of fever, a history of recent infection or immunization, and some degree of impairment of consciousness, perhaps even coma; these features are not typically seen in MS.  Children are more likely than adults to have ADEM, whereas MS is a rare diagnosis in children.  In addition, ADEM usually consists of a single episode or attack of widespread myelin damage, while MS features many attacks over the course of time. Doctors will often use imaging techniques, such as MRI (magnetic resonance imaging), to search for old and new lesions (areas of damage) on the brain.  The presence of older brain lesions on MRI suggest that the condition may be MS rather than ADEM, since MS can cause brain lesions before symptoms become obvious.  In rare situations, a brain biopsy may be necessary to differentiate between ADEM and some other diseases that involve inflammation and damage to myelin.

MalaCards based summary : Acute Disseminated Encephalomyelitis, also known as acute disseminated encephalitis, is related to allergic encephalomyelitis and panencephalitis, subacute sclerosing. An important gene associated with Acute Disseminated Encephalomyelitis is MBP (Myelin Basic Protein), and among its related pathways/superpathways are Class I MHC mediated antigen processing and presentation and Cytokine Signaling in Immune system. The drugs Antibodies, Blocking and Vaccines have been mentioned in the context of this disorder. Affiliated tissues include brain, spinal cord and eye.

Disease Ontology : 12 An encephalomyelitis characterized by inflammation locatedin brain and locatedin spinal cord that damages myelin. It usually occurs after viral infection, but also following vaccination, bacterial or parasitic infection.

NIH Rare Diseases : 53 Acute disseminated encephalomyelitis (ADEM) is a neurological condition characterized by a brief but intense attack of inflammation in the brain and spinal cord. This may lead to damage of the layer of insulation around the nerves (myelin) within affected areas. ADEM often follows viral infection, or less often, vaccinations for measles, mumps, or rubella (MMR). Symptoms usually appear rapidly, beginning with fever, fatigue, headache, nausea and vomiting. Treatment for ADEM is targeted at suppressing inflammation in the brain using anti-inflammatory drugs. Most people begin to recover within days, with total or near-total recovery within a few months. Some people may have lifelong neurological impairments, and very rarely, severe cases can be fatal.

Wikipedia : 75 Acute disseminated encephalomyelitis (ADEM), or acute demyelinating encephalomyelitis, is a rare... more...

Related Diseases for Acute Disseminated Encephalomyelitis

Diseases related to Acute Disseminated Encephalomyelitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1724, show less)
# Related Disease Score Top Affiliating Genes
1 allergic encephalomyelitis 33.1 MOG MBP
2 panencephalitis, subacute sclerosing 33.0 MOG MBP
3 pediatric multiple sclerosis 31.1 MOG HLA-DRB1 HLA-DQB1
4 neuritis 30.8 MOG MBP AQP4
5 acute transverse myelitis 30.8 IL10 AQP4
6 myelitis 30.8 MOG MBP AQP4
7 demyelinating disease 30.6 MOG MBP IL10 AQP4
8 viral encephalitis 30.6 MBP IL10
9 transverse myelitis 30.5 MBP IL10 AQP4
10 herpes zoster 30.5 IL10 HLA-B
11 intermediate uveitis 30.4 IL10 HLA-B
12 brain injury 30.4 MBP IL10
13 hematopoietic stem cell transplantation 30.4 IL10 HLA-B
14 pure red-cell aplasia 30.3 HLA-DRB1 HLA-DQB1
15 toxoplasmosis 30.3 IL10 HLA-DQB1 HLA-DQA1
16 alexia 30.2 MBP AQP4
17 optic nerve disease 30.1 MOG MBP AQP4
18 optic neuritis 30.1 MOG MBP HLA-DRB1 AQP4
19 rubella 30.0 MOG IL10 HLA-DRB1 HLA-DQB1 HLA-B
20 rheumatic fever 30.0 IL10 HLA-DRB1 HLA-DQA1
21 peripheral nervous system disease 30.0 MOG MBP AQP4
22 rheumatic disease 30.0 IL10 HLA-DRB1 HLA-B
23 endometritis 29.9 HLA-DQB1 HLA-DQA1
24 complex regional pain syndrome 29.9 IL10 HLA-B
25 hypersomnia 29.9 HLA-DRB1 HLA-DQB1 HCRT
26 dengue hemorrhagic fever 29.9 IL10 HLA-DRB1 HLA-B
27 neuroretinitis 29.8 MOG AQP4
28 polyradiculoneuropathy 29.8 MBP IL10 HLA-DRB1
29 congenital toxoplasmosis 29.7 HLA-DQB1 HLA-DQA1
30 graft-versus-host disease 29.7 IL10 HLA-DRB1 HLA-DQB1 HLA-B
31 nervous system disease 29.7 MOG MBP IL10 AQP4
32 microscopic colitis 29.6 HLA-DRB1 HLA-DQB1
33 traumatic brain injury 29.6 MBP IL10 AQP4
34 balo concentric sclerosis 29.6 MOG MBP AQP4
35 spondyloarthropathy 29.5 IL10 HLA-B
36 arthritis 29.5 IL10 HLA-DRB1 HLA-DQB1
37 guillain-barre syndrome 29.5 MBP HLA-DQB1 HLA-DQA1 HCRT
38 diabetes mellitus 29.4 HLA-DRB1 HLA-DQB1 HLA-DQA1 HLA-B
39 autoimmune disease 29.3 MOG MBP IL10 HLA-DRB1 HLA-DQB1
40 relapsing-remitting multiple sclerosis 29.3 MOG MBP IL10 AQP4
41 sleep disorder 29.2 MOG HCRT
42 systemic lupus erythematosus 29.2 IL10 HLA-DRB1 HLA-DQB1 HLA-DQA1 HLA-DPA1
43 asthma 29.1 IL10 HLA-DRB1 HLA-DQB1 HLA-DQA1
44 multiple sclerosis 29.1 MOG MBP IL10 HLA-DRB1 HLA-DQB1 AQP4
45 central nervous system disease 29.0 MOG MBP HCRT AQP4
46 leishmaniasis 28.9 IL10 HLA-DRB1 HLA-DQB1 HLA-DQA1
47 rheumatoid arthritis 28.8 IL10 HLA-DRB1 HLA-DQB1 HLA-DQA1 HLA-B
48 diabetes mellitus, insulin-dependent 28.7 IL10 HLA-DRB1 HLA-DQB1 HLA-DQA1
49 neuromyelitis optica 28.7 MOG MBP HLA-DRB1 HCRT AQP4
50 internuclear ophthalmoplegia 28.5 MOG MBP HCRT AQP4
51 narcolepsy 28.3 MOG HLA-DRB1 HLA-DQB1 HLA-DQA1 HCRT
52 alzheimer disease 12.4
53 hyper-ige recurrent infection syndrome 1, autosomal dominant 12.1
54 acute hemorrhagic leukoencephalitis 11.9
55 immunodeficiency 27b 11.9
56 myopathy, centronuclear, 1 11.9
57 postinfectious encephalomyelitis 11.8
58 early-onset, autosomal dominant alzheimer disease 11.7
59 alzheimer disease 2 11.7
60 hypocalcemia, autosomal dominant 1 11.7
61 anauxetic dysplasia 1 11.7
62 alcohol dependence 11.6
63 dermatitis, atopic 11.6
64 alzheimer disease 3 11.6
65 striatonigral degeneration, infantile 11.5
66 acute flaccid myelitis 11.5
67 immune-mediated encephalomyelitis 11.5
68 alzheimer disease 6 11.5
69 frontotemporal lobar degeneration with tdp43 inclusions, grn-related 11.5
70 polycystic liver disease 11.5
71 renal tubular acidosis, distal, autosomal dominant 11.4
72 frontotemporal dementia 11.4
73 spinal muscular atrophy, lower extremity-predominant, 1, autosomal dominant 11.3
74 emery-dreifuss muscular dystrophy 7, autosomal dominant 11.3
75 parkinson disease, late-onset 11.3
76 posterior cortical atrophy 11.3
77 pick disease of brain 11.3
78 dementia, lewy body 11.3
79 keratomalacia 11.3
80 hypoascorbemia 11.3
81 rickets 11.3
82 eosinophilic granulomatosis with polyangiitis 11.3
83 semantic dementia 11.3
84 epidermolysis bullosa dystrophica, autosomal dominant 11.2
85 familial mediterranean fever, autosomal dominant 11.2
86 palmoplantar keratoderma i, striate, focal, or diffuse 11.2
87 slowed nerve conduction velocity, autosomal dominant 11.2
88 mitochondrial dna depletion syndrome 12a , autosomal dominant 11.2
89 distal renal tubular acidosis 11.2
90 immunodeficiency 27a 11.2
91 hyper-ige recurrent infection syndrome 2, autosomal recessive 11.2
92 immunodeficiency 31a 11.2
93 brachyolmia 11.2
94 spinal muscular atrophy 11.2
95 ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant 11.1
96 alzheimer disease mitochondrial 11.1
97 autosomal dominant spastic ataxia 11.1
98 autosomal dominant proximal renal tubular acidosis 11.1
99 anemia, congenital dyserythropoietic, type iii 11.0
100 heinz body anemias 11.0
101 parkinson disease 1, autosomal dominant 11.0
102 spinocerebellar ataxia 2 11.0
103 vasculopathy, retinal, with cerebral leukodystrophy 11.0
104 epidermolysis bullosa junctionalis with pyloric atresia 11.0
105 fanconi anemia, complementation group a 11.0
106 fructose intolerance, hereditary 11.0
107 spinal muscular atrophy, type i 11.0
108 spinal muscular atrophy, type ii 11.0
109 esophagitis, eosinophilic, 1 11.0
110 centronuclear myopathy 11.0
111 articulation disorder 11.0
112 gerstmann syndrome 11.0
113 chromosome 17q11.2 deletion syndrome 11.0
114 familiar chronic mucocutaneous candidiasis 11.0
115 rohhad 11.0
116 encephalitis 10.8
117 encephalopathy 10.7
118 ataxia and polyneuropathy, adult-onset 10.7
119 pain agnosia 10.6
120 ocular motor apraxia 10.6
121 hypoglycemia 10.6
122 measles 10.6
123 idiopathic achalasia 10.5 IL10 HLA-DQB1
124 meningoencephalitis 10.5
125 influenza 10.5
126 chickenpox 10.5
127 achalasia, familial esophageal 10.5 HLA-DQB1 HLA-DQA1
128 mumps 10.5
129 cytomegalovirus retinitis 10.4 HLA-DQB1 HLA-B
130 dementia 10.4
131 meningitis 10.4
132 limbic encephalitis with lgi1 antibodies 10.4 HLA-DRB1 HLA-DQB1
133 aphasia 10.4
134 autoimmune polyglandular syndrome type 3 10.4 HLA-DRB1 HLA-DQB1
135 pathologic nystagmus 10.4
136 type ii mixed cryoglobulinemia 10.4 HLA-DRB1 HLA-DQB1
137 lichen planopilaris 10.4 HLA-DRB1 HLA-DQB1
138 metal allergy 10.4 HLA-DRB1 HLA-DQB1
139 recurrent respiratory papillomatosis 10.4 HLA-DRB1 HLA-DQB1
140 malaria 10.4
141 aseptic meningitis 10.4
142 facial paralysis 10.4
143 juvenile myasthenia gravis 10.4 IL10 HLA-DRB1
144 lichen sclerosus 10.4 HLA-DRB1 HLA-DQB1
145 aphthous stomatitis 10.3 IL10 HLA-B
146 whipple disease 10.3 HLA-DRB1 HLA-DQB1
147 cervical dystonia 10.3 HLA-DQB1 HLA-DQA1
148 osteonecrosis of the jaw 10.3 HLA-DRB1 HLA-DQB1
149 poliomyelitis 10.3
150 paraplegia 10.3
151 herpes simplex 10.3
152 vasculitis 10.3
153 neuropathy 10.3
154 dermatitis 10.3
155 postherpetic neuralgia 10.3 HLA-DRB1 HLA-B
156 japanese encephalitis 10.3
157 respiratory failure 10.3
158 rabies 10.3
159 idiopathic inflammatory myopathy 10.3 HLA-DRB1 HLA-B
160 pars planitis 10.3 HLA-DRB1 HLA-B
161 discoid lupus erythematosus 10.3 IL10 HLA-DRB1
162 aceruloplasminemia 10.3
163 hemiplegia 10.3
164 hepatitis a 10.3
165 quadriplegia 10.3
166 headache 10.3
167 cystic echinococcosis 10.3 IL10 HLA-DRB1
168 berylliosis 10.3 HLA-DRB1 HLA-DPA1
169 nontuberculous mycobacterial lung disease 10.3 HLA-DRB1 HLA-B
170 rapidly involuting congenital hemangioma 10.3
171 dermatitis herpetiformis 10.2 HLA-DQB1 HLA-DQA1
172 neutropenia 10.2
173 exanthem 10.2
174 tetanus 10.2
175 mutism 10.2
176 lupus erythematosus 10.2
177 hypercholesterolemia, familial, 1 10.2
178 depression 10.2
179 alveolar echinococcosis 10.2 HLA-DRB1 HLA-B
180 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.2
181 hirata disease 10.2 HLA-DRB1 HLA-DQA1
182 congestive heart failure 10.2
183 ocular cicatricial pemphigoid 10.2 HLA-DRB1 HLA-DQB1
184 eosinophilia-myalgia syndrome 10.2 HLA-DRB1 HLA-DQA1
185 ischemia 10.2
186 coronary heart disease 1 10.2
187 lipid metabolism disorder 10.2
188 kearns-sayre syndrome 10.2
189 lymphoma 10.2
190 visual epilepsy 10.2
191 dengue disease 10.2
192 locked-in syndrome 10.2
193 plasmodium vivax malaria 10.2
194 diarrhea 10.2
195 polyneuropathy 10.2
196 squamous cell papilloma 10.2
197 papilloma 10.2
198 brain edema 10.2
199 bacterial meningitis 10.2
200 cytomegalovirus infection 10.2
201 seizure disorder 10.2
202 tremor 10.2
203 sympathetic ophthalmia 10.2 HLA-DRB1 HLA-DQA1
204 cervical cancer 10.2
205 open-angle glaucoma 10.2
206 vascular dementia 10.2
207 autoimmune pancreatitis 10.2 IL10 HLA-DRB1
208 heart disease 10.2
209 vascular disease 10.2
210 lung cancer 10.2
211 uveal disease 10.2 IL10 HLA-B
212 hyperlipoproteinemia, type iii 10.2
213 coronary artery anomaly 10.2
214 mental depression 10.2
215 dental caries 10.2
216 amyloidosis 10.2
217 idiopathic neutropenia 10.2 IL10 HLA-DRB1
218 arteries, anomalies of 10.2
219 scoliosis 10.1
220 kidney disease 10.1
221 pfeiffer syndrome 10.1
222 immune deficiency disease 10.1
223 myeloma, multiple 10.1
224 yemenite deaf-blind hypopigmentation syndrome 10.1
225 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.1
226 hydrops, lactic acidosis, and sideroblastic anemia 10.1
227 variola major 10.1
228 agraphia 10.1
229 bacterial infectious disease 10.1
230 common cold 10.1
231 leukodystrophy 10.1
232 pertussis 10.1
233 diphtheria 10.1
234 acute cystitis 10.1
235 status epilepticus 10.1
236 leptospirosis 10.1
237 gastroenteritis 10.1
238 dysgraphia 10.1
239 dystonia 10.1
240 pneumonia 10.1
241 smallpox 10.1
242 autoimmune encephalitis 10.1
243 neuromyelitis optica spectrum disorder 10.1
244 hypotonia 10.1
245 myoclonus 10.1
246 autism 10.1
247 aging 10.1
248 pulmonary disease, chronic obstructive 10.1
249 adenoma 10.1
250 chronic kidney disease 10.1
251 48,xyyy 10.1
252 idiopathic hypersomnia 10.1 HLA-DQB1 HCRT
253 hepatocellular carcinoma 10.1
254 glaucoma, primary open angle 10.1
255 small cell cancer of the lung 10.1
256 pulmonary alveolar microlithiasis 10.1
257 atrial fibrillation 10.1
258 osteoarthritis 10.1
259 pulmonary embolism 10.1
260 peanut allergy 10.1 IL10 HLA-DRB1 HLA-DQB1
261 recurrent hypersomnia 10.1 HLA-DQB1 HCRT
262 mixed connective tissue disease 10.1 IL10 HLA-DRB1
263 schizophrenia 10.1
264 major depressive disorder 10.1
265 hyperglycemia 10.1
266 bladder cancer 10.1
267 ovarian cancer 10.1
268 triiodothyronine receptor auxiliary protein 10.1
269 constipation 10.1
270 pityriasis rosea 10.1 HLA-DRB1 HLA-DQB1 HLA-B
271 atherosclerosis susceptibility 10.1
272 body mass index quantitative trait locus 1 10.1
273 idiopathic scoliosis 10.1
274 lymphocytic leukemia 10.1
275 rectum cancer 10.1
276 adenocarcinoma 10.1
277 fatty liver disease 10.1
278 geographic tongue 10.1 HLA-DRB1 HLA-DQB1 HLA-B
279 colorectal cancer 10.1
280 hypertension, essential 10.1
281 osteoporosis 10.1
282 pancreatic cancer 10.1
283 anxiety 10.1
284 bone mineral density quantitative trait locus 8 10.1
285 bone mineral density quantitative trait locus 15 10.1
286 liver disease 10.1
287 chronic pain 10.1
288 central pontine myelinolysis 10.1 MBP AQP4
289 paraneoplastic pemphigus 10.1 HLA-DRB1 HLA-DQB1 HLA-B
290 autism spectrum disorder 10.1
291 cerebral palsy 10.1
292 pik3ca-related overgrowth syndrome 10.1
293 thyroid carcinoma 10.1
294 chronic beryllium disease 10.1 HLA-DRB1 HLA-DQB1 HLA-DPA1
295 hemorrhagic fever with renal syndrome 10.1 HLA-DRB1 HLA-B
296 reactive arthritis 10.1 IL10 HLA-B
297 ocular hypertension 10.0
298 acute myocardial infarction 10.0
299 atrial standstill 1 10.0
300 attention deficit-hyperactivity disorder 10.0
301 hepatitis c virus 10.0
302 dengue virus 10.0
303 chorea, childhood-onset, with psychomotor retardation 10.0
304 zika fever 10.0
305 viral meningitis 10.0
306 neurogenic bladder 10.0
307 common variable immunodeficiency 10.0
308 choreatic disease 10.0
309 miller fisher syndrome 10.0
310 post-vaccinal encephalitis 10.0
311 plasmodium falciparum malaria 10.0
312 hepatitis c 10.0
313 hepatitis 10.0
314 pharyngitis 10.0
315 kluver-bucy syndrome 10.0
316 purpura 10.0
317 cerebritis 10.0
318 lactic acidosis 10.0
319 cranial nerve palsy 10.0
320 central nervous system vasculitis 10.0
321 hemolytic anemia 10.0
322 gliomatosis cerebri 10.0
323 bronchitis 10.0
324 lymphopenia 10.0
325 axonal neuropathy 10.0
326 intracranial hypertension 10.0
327 47,xyy 10.0
328 cytokine deficiency 10.0
329 herpes simplex encephalitis 10.0
330 limbic encephalitis 10.0
331 zika virus infection 10.0
332 dysphagia 10.0
333 paresthesia 10.0
334 spasticity 10.0
335 specific language disorder 10.0
336 isolated optic neuritis 10.0
337 bickerstaff brainstem encephalitis 10.0
338 infectious encephalitis 10.0
339 postinfectious encephalitis 10.0
340 prostate cancer 10.0
341 scoliosis, isolated 1 10.0
342 methane production 10.0
343 mucositis 10.0
344 rhinitis 10.0
345 hypertriglyceridemia, familial 10.0
346 angina pectoris 10.0
347 echinococcosis 10.0 IL10 HLA-DRB1 HLA-B
348 pulmonary hypertension, primary, 1 10.0
349 down syndrome 10.0
350 human immunodeficiency virus type 1 10.0
351 myelodysplastic syndrome 10.0
352 substance abuse 10.0
353 liver cirrhosis 10.0
354 psoriasis 10.0
355 oligoarticular juvenile idiopathic arthritis 10.0 HLA-DRB1 HLA-DQB1 HLA-DQA1
356 allergic rhinitis 10.0
357 non-alcoholic fatty liver disease 10.0
358 alcohol use disorder 10.0
359 pustulosis of palm and sole 10.0
360 b-cell lymphoma 10.0
361 appendicitis 10.0
362 lung disease 10.0
363 focal epithelial hyperplasia 10.0 HLA-DRB1 HLA-DQB1 HLA-DQA1
364 kleine-levin hibernation syndrome 10.0 HLA-DQB1 HCRT
365 intraocular pressure quantitative trait locus 10.0
366 conduct disorder 10.0
367 hyperinsulinism 10.0
368 intermediate coronary syndrome 10.0
369 tropical spastic paraparesis 10.0 IL10 HLA-B
370 breast cancer 10.0
371 leukemia, chronic lymphocytic 10.0
372 nasopharyngeal carcinoma 10.0
373 myocardial infarction 10.0
374 diffuse large b-cell lymphoma 10.0
375 disease of mental health 10.0
376 skin disease 10.0
377 leukemia, b-cell, chronic 10.0
378 histoplasmosis 9.9 HLA-DRB1 HLA-DQA1 HLA-B
379 amyotrophic lateral sclerosis 1 9.9
380 cystic fibrosis 9.9
381 leprosy 3 9.9
382 endometrial cancer 9.9
383 microvascular complications of diabetes 3 9.9
384 microvascular complications of diabetes 4 9.9
385 microvascular complications of diabetes 6 9.9
386 microvascular complications of diabetes 7 9.9
387 sleep apnea 9.9
388 bone resorption disease 9.9
389 pre-eclampsia 9.9
390 melanoma 9.9
391 lateral sclerosis 9.9
392 plague 9.9
393 infertility 9.9
394 eating disorder 9.9
395 in situ carcinoma 9.9
396 hansen's disease 9.9
397 head injury 9.9
398 gastroesophageal reflux 9.9
399 creutzfeldt-jakob disease 9.9
400 diabetes mellitus, noninsulin-dependent 9.9
401 neural tube defects 9.9
402 tobacco addiction 9.9
403 smoking as a quantitative trait locus 3 9.9
404 fatty liver disease, nonalcoholic 1 9.9
405 pulmonary hypertension 9.9
406 oppositional defiant disorder 9.9
407 iron metabolism disease 9.9
408 radiculopathy 9.9
409 schizoaffective disorder 9.9
410 fibromyalgia 9.9
411 takayasu arteritis 9.9 HLA-DRB1 HLA-DQA1 HLA-B
412 adrenoleukodystrophy 9.9
413 chlamydia pneumonia 9.9
414 mitochondrial metabolism disease 9.9
415 adrenomyeloneuropathy 9.9
416 syncope 9.9
417 connective tissue disease 9.9 IL10 HLA-DRB1 HLA-DQA1
418 anisocoria 9.9
419 episodic kinesigenic dyskinesia 1 9.9
420 migraine with or without aura 1 9.9
421 myositis 9.9
422 obsessive-compulsive disorder 9.9
423 hypokalemic periodic paralysis, type 1 9.9
424 porphyria, acute intermittent 9.9
425 strabismus 9.9
426 thrombocytopenic purpura, autoimmune 9.9
427 thrombophilia due to thrombin defect 9.9
428 digeorge syndrome 9.9
429 torticollis 9.9
430 anemia, autoimmune hemolytic 9.9
431 lymphoma, hodgkin, classic 9.9
432 epilepsy, focal, with speech disorder and with or without mental retardation 9.9
433 melanosis, neurocutaneous 9.9
434 leigh syndrome 9.9
435 proteasome-associated autoinflammatory syndrome 1 9.9
436 neuroblastoma 1 9.9
437 rheumatic fever-related antigen 9.9
438 spastic pseudosclerosis 9.9
439 incontinentia pigmenti 9.9
440 mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes 9.9
441 stroke, ischemic 9.9
442 leukemia, acute myeloid 9.9
443 ventricular fibrillation, paroxysmal familial, 1 9.9
444 lymphoma, non-hodgkin, familial 9.9
445 legionnaire disease 9.9
446 west nile virus 9.9
447 major affective disorder 8 9.9
448 major affective disorder 9 9.9
449 multiple sclerosis 3 9.9
450 early repolarization associated with ventricular fibrillation 9.9
451 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 9.9
452 striatal degeneration, autosomal dominant 2 9.9
453 deficiency anemia 9.9
454 west syndrome 9.9
455 streptococcus pneumonia 9.9
456 pemphigus gestationis 9.9
457 chikungunya 9.9
458 rocky mountain spotted fever 9.9
459 dengue shock syndrome 9.9
460 pontiac fever 9.9
461 aspiration pneumonia 9.9
462 swine influenza 9.9
463 epidemic typhus 9.9
464 lennox-gastaut syndrome 9.9
465 inflammatory bowel disease 9.9
466 anaplastic large cell lymphoma 9.9
467 apraxia 9.9
468 visual agnosia 9.9
469 crohn's colitis 9.9
470 cardiac arrest 9.9
471 cryptococcal meningitis 9.9
472 hyper ige syndrome 9.9
473 sensorineural hearing loss 9.9
474 parotitis 9.9
475 legionellosis 9.9
476 charcot-marie-tooth disease 9.9
477 eastern equine encephalitis 9.9
478 tooth disease 9.9
479 dissociative disorder 9.9
480 cholesteatoma of middle ear 9.9
481 pasteurellosis 9.9
482 spotted fever 9.9
483 chlamydia 9.9
484 choroiditis 9.9
485 horner's syndrome 9.9
486 oculomotor nerve paralysis 9.9
487 cauda equina syndrome 9.9
488 cortical blindness 9.9
489 allergic hypersensitivity disease 9.9
490 low compliance bladder 9.9
491 detrusor sphincter dyssynergia 9.9
492 acute leukemia 9.9
493 dilated cardiomyopathy 9.9
494 branch retinal artery occlusion 9.9
495 uveitis 9.9
496 typhoid fever 9.9
497 porphyria 9.9
498 mycoplasma pneumoniae pneumonia 9.9
499 scrub typhus 9.9
500 neurosarcoidosis 9.9
501 acute retrobulbar neuritis 9.9
502 mixed malaria 9.9
503 neuroleptic malignant syndrome 9.9
504 pemphigoid gestationis 9.9
505 reye syndrome 9.9
506 papilledema 9.9
507 thrombocytopenia 9.9
508 conversion disorder 9.9
509 impotence 9.9
510 hepatitis b 9.9
511 psychotic disorder 9.9
512 landau-kleffner syndrome 9.9
513 agammaglobulinemia 9.9
514 glomerulonephritis 9.9
515 glioblastoma multiforme 9.9
516 central nervous system lymphoma 9.9
517 hyper ige recurrent infection syndrome 1 9.9
518 vaccinia 9.9
519 bipolar disorder 9.9
520 mood disorder 9.9
521 pleural empyema 9.9
522 agnosia 9.9
523 systemic scleroderma 9.9
524 myopathy 9.9
525 akinetic mutism 9.9
526 polyradiculopathy 9.9
527 seminoma 9.9
528 nominal aphasia 9.9
529 ideomotor apraxia 9.9
530 movement disease 9.9
531 chronic inflammatory demyelinating polyradiculoneuropathy 9.9
532 demyelinating polyneuropathy 9.9
533 von economo's disease 9.9
534 third cranial nerve disease 9.9
535 adenosine deaminase deficiency 9.9
536 combined t cell and b cell immunodeficiency 9.9
537 cerebrovascular disease 9.9
538 mitochondrial myopathy 9.9
539 thyroiditis 9.9
540 muscular atrophy 9.9
541 end stage renal failure 9.9
542 localized scleroderma 9.9
543 retinal artery occlusion 9.9
544 bullous pemphigoid 9.9
545 malignant histiocytosis 9.9
546 subacute delirium 9.9
547 viral exanthem 9.9
548 myeloid leukemia 9.9
549 crohn's disease 9.9
550 mitochondrial encephalomyopathy 9.9
551 learning disability 9.9
552 mechanical strabismus 9.9
553 yellow fever 9.9
554 toxocariasis 9.9
555 acute graft versus host disease 9.9
556 acute leukemia of ambiguous lineage 9.9
557 acute necrotizing encephalopathy 9.9
558 broken heart syndrome 9.9
559 central pain syndrome 9.9
560 chronic graft versus host disease 9.9
561 foix chavany marie syndrome 9.9
562 glioblastoma 9.9
563 glioma 9.9
564 haemophilus influenzae 9.9
565 hhv-6 encephalitis 9.9
566 macrophage activation syndrome 9.9
567 mitochondrial encephalomyopathy lactic acidosis and stroke-like episodes 9.9
568 pediatric acute-onset neuropsychiatric syndrome 9.9
569 pontine hemorrhage 9.9
570 primary central nervous system lymphoma 9.9
571 pseudobulbar affect 9.9
572 pure autonomic failure 9.9
573 rasmussen encephalitis 9.9
574 spastic paraparesis 9.9
575 x-linked charcot-marie-tooth disease 9.9
576 aneurysm 9.9
577 back pain 9.9
578 hereditary neuropathies 9.9
579 hypertonia 9.9
580 spinal cord injury 9.9
581 glial tumor 9.9
582 periodic paralysis 9.9
583 pneumococcal meningitis 9.9
584 histiocytic sarcoma 9.9
585 rare surgical neurologic disease 9.9
586 chronic encephalitis 9.9
587 cardiogenic shock 9.9
588 acute motor axonal neuropathy 9.9
589 red cell aplasia 9.9
590 cerebral amyloid angiopathy, cst3-related 9.9
591 cardiac conduction defect 9.9
592 insulin-like growth factor i 9.9
593 body mass index quantitative trait locus 11 9.9
594 supranuclear palsy, progressive, 1 9.9
595 body mass index quantitative trait locus 9 9.9
596 macular degeneration, age-related, 1 9.9
597 homocysteinemia 9.9
598 body mass index quantitative trait locus 8 9.9
599 body mass index quantitative trait locus 4 9.9
600 body mass index quantitative trait locus 10 9.9
601 body mass index quantitative trait locus 7 9.9
602 body mass index quantitative trait locus 12 9.9
603 body mass index quantitative trait locus 14 9.9
604 microvascular complications of diabetes 5 9.9
605 leukemia, acute lymphoblastic 9.9
606 body mass index quantitative trait locus 18 9.9
607 cholangiocarcinoma 9.9
608 body mass index quantitative trait locus 19 9.9
609 body mass index quantitative trait locus 20 9.9
610 follicular lymphoma 9.9
611 pervasive developmental disorder 9.9
612 ductal carcinoma in situ 9.9
613 prostatic hypertrophy 9.9
614 mitral valve insufficiency 9.9
615 bell's palsy 9.9
616 hyperparathyroidism 9.9
617 neuroendocrine tumor 9.9
618 dyspepsia 9.9
619 aortic aneurysm 9.9
620 intrahepatic cholangiocarcinoma 9.9
621 peritonitis 9.9
622 cervix uteri carcinoma in situ 9.9
623 stomatitis 9.9
624 alopecia 9.9
625 cervical intraepithelial neoplasia 9.9
626 fibrosis of extraocular muscles, congenital, 1 9.9
627 hair whorl 9.9
628 renal cell carcinoma, nonpapillary 9.9
629 osteogenic sarcoma 9.9
630 peripheral vascular disease 9.9
631 sexual disorder 9.9
632 endocarditis 9.9
633 glucose intolerance 9.9
634 hydrocephalus 9.9
635 polycystic ovary syndrome 9.9
636 gestational diabetes 9.9
637 leukemia 9.9
638 toxic shock syndrome 9.9
639 squamous cell carcinoma 9.9
640 enthesopathy 9.9
641 prostatic adenoma 9.9
642 severe combined immunodeficiency 9.9
643 behavioral variant of frontotemporal dementia 9.9
644 congenital hydrocephalus 9.9
645 obsolete: squamous cell carcinoma of head and neck 9.9
646 esophageal cancer 9.8
647 prostatic hyperplasia, benign 9.8
648 gallbladder disease 1 9.8
649 lung cancer susceptibility 3 9.8
650 gastric cancer 9.8
651 leukemia, acute lymphoblastic 3 9.8
652 helix syndrome 9.8
653 spastic cerebral palsy 9.8
654 withdrawal disorder 9.8
655 inguinal hernia 9.8
656 thrombosis 9.8
657 osteomyelitis 9.8
658 primary hyperparathyroidism 9.8
659 gout 9.8
660 eclampsia 9.8
661 hypothyroidism 9.8
662 cholera 9.8
663 duodenal ulcer 9.8
664 epilepsy 9.8
665 focal epilepsy 9.8
666 sensory peripheral neuropathy 9.8
667 hemangioma 9.8
668 kidney cancer 9.8
669 benign mesothelioma 9.8
670 bilirubin metabolic disorder 9.8
671 tic disorder 9.8
672 newcastle disease 9.8
673 skin carcinoma 9.8
674 conjunctivitis 9.8
675 myocarditis 9.8
676 periodontitis 9.8
677 ulcerative colitis 9.8
678 achalasia 9.8
679 allergic asthma 9.8
680 hypereosinophilic syndrome 9.8
681 chromosomal triplication 9.8
682 ovarian epithelial cancer 9.8
683 spinal cord disease 9.8 MOG MBP AQP4
684 cranial nerve disease 9.8 MOG MBP AQP4
685 neurofibromatosis, type ii 9.8
686 pulmonary fibrosis, idiopathic 9.8
687 scleroderma, familial progressive 9.8
688 varicose veins 9.8
689 celiac disease 1 9.8
690 sudden infant death syndrome 9.8
691 arts syndrome 9.8
692 barrett esophagus 9.8
693 mantle cell lymphoma 9.8
694 metabolic acidosis 9.8
695 sarcoma 9.8
696 hepatic coma 9.8
697 pyloric stenosis 9.8
698 hepatic encephalopathy 9.8
699 pneumothorax 9.8
700 acromegaly 9.8
701 idiopathic interstitial pneumonia 9.8
702 pulmonary tuberculosis 9.8
703 acute kidney failure 9.8
704 gingivitis 9.8
705 temporal lobe epilepsy 9.8
706 pancreatic ductal adenocarcinoma 9.8
707 pulmonary fibrosis 9.8
708 gastritis 9.8
709 tricuspid valve insufficiency 9.8
710 syphilis 9.8
711 spindle cell sarcoma 9.8
712 coronary stenosis 9.8
713 panic disorder 9.8
714 acquired immunodeficiency syndrome 9.8
715 spinal stenosis 9.8
716 cataract 9.8
717 polycythemia 9.8
718 cholangitis 9.8
719 muscular dystrophy 9.8
720 acute respiratory distress syndrome 9.8
721 corticobasal degeneration 9.8
722 posttransplant acute limbic encephalitis 9.8
723 rare disease in surgical orthopedic 9.8
724 ventral hernia 9.8
725 panuveitis 9.8 IL10 HLA-DRB1 HLA-DQB1 HLA-B
726 aortic aneurysm, familial abdominal, 1 9.7
727 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.7
728 spastic paraplegia 4, autosomal dominant 9.7
729 suppressor of tumorigenicity 3 9.7
730 enterocolitis 9.7
731 hutterite cerebroosteonephrodysplasia syndrome 9.7
732 squamous cell carcinoma, head and neck 9.7
733 helicobacter pylori infection 9.7
734 branchiootic syndrome 1 9.7
735 anorexia nervosa 9.7
736 psoriatic arthritis 9.7
737 leukemia, chronic myeloid 9.7
738 tendinopathy 9.7
739 tendinitis 9.7
740 estrogen-receptor positive breast cancer 9.7
741 colitis 9.7
742 thalassemia 9.7
743 nasopharyngitis 9.7
744 amnestic disorder 9.7
745 trachoma 9.7
746 pulmonary edema 9.7
747 myopia 9.7
748 esophagitis 9.7
749 dysthymic disorder 9.7
750 dysentery 9.7
751 hypertrophic pyloric stenosis 9.7
752 carotid stenosis 9.7
753 patent foramen ovale 9.7
754 premature ejaculation 9.7
755 shoulder impingement syndrome 9.7
756 cholecystitis 9.7
757 transient cerebral ischemia 9.7
758 ankylosis 9.7
759 thrombophilia 9.7
760 hereditary spastic paraplegia 9.7
761 basal cell carcinoma 9.7
762 opiate dependence 9.7
763 synovitis 9.7
764 acute pancreatitis 9.7
765 fibrosarcoma 9.7
766 pituitary adenoma 9.7
767 heart valve disease 9.7
768 acute stress disorder 9.7
769 anthrax disease 9.7
770 peptic ulcer disease 9.7
771 hyperthyroidism 9.7
772 rem sleep behavior disorder 9.7
773 croup 9.7
774 systolic heart failure 9.7
775 hypertrophic cardiomyopathy 9.7
776 oral cancer 9.7
777 pancreatic neuroendocrine tumor 9.7
778 soft tissue sarcoma 9.7
779 anoxia 9.7
780 virus-associated trichodysplasia spinulosa 9.7
781 glaucomatocyclitic crisis 9.7 HLA-DRB1 HLA-DQB1 HLA-DPA1 HLA-B
782 narcolepsy 2 9.7 HLA-DRB1 HLA-DQB1 HCRT
783 idiopathic bronchiectasis 9.7 HLA-DRB1 HLA-DQB1 HLA-DQA1 HLA-B
784 spondyloarthropathy 1 9.7
785 progressive familial heart block, type ia 9.7
786 burkitt lymphoma 9.7
787 carpal tunnel syndrome 9.7
788 exudative vitreoretinopathy 1 9.7
789 hand skill, relative 9.7
790 thyroid carcinoma, familial medullary 9.7
791 papillomatosis, confluent and reticulated 9.7
792 pectus excavatum 9.7
793 pheochromocytoma 9.7
794 pelvic organ prolapse 9.7
795 retinal detachment 9.7
796 retinoblastoma 9.7
797 schistosoma mansoni infection, susceptibility/ 9.7
798 vitiligo-associated multiple autoimmune disease susceptibility 6 9.7
799 chondrosarcoma 9.7
800 hydrocephalus, normal-pressure 9.7
801 polycythemia vera 9.7
802 senile plaque formation 9.7
803 thymoma, familial 9.7
804 graves disease 1 9.7
805 vitiligo-associated multiple autoimmune disease susceptibility 1 9.7
806 bulimia nervosa 9.7
807 aspergillosis 9.7
808 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.7
809 acute diarrhea 9.7
810 hypophosphatemia 9.7
811 peripheral artery disease 9.7
812 oral squamous cell carcinoma 9.7
813 adrenal gland pheochromocytoma 9.7
814 infective endocarditis 9.7
815 polycystic kidney disease 9.7
816 left bundle branch hemiblock 9.7
817 bubonic plague 9.7
818 spastic diplegia 9.7
819 hydronephrosis 9.7
820 anogenital venereal wart 9.7
821 hypoparathyroidism 9.7
822 adult respiratory distress syndrome 9.7
823 pyelonephritis 9.7
824 infant gynecomastia 9.7
825 patau syndrome 9.7
826 inflammatory spondylopathy 9.7
827 goiter 9.7
828 alcoholic hepatitis 9.7
829 graves' disease 9.7
830 gynecomastia 9.7
831 color blindness 9.7
832 familial hypercholesterolemia 9.7
833 interstitial cystitis 9.7
834 schistosomiasis 9.7
835 generalized anxiety disorder 9.7
836 candidiasis 9.7
837 urticaria 9.7
838 endogenous depression 9.7
839 cystitis 9.7
840 heart septal defect 9.7
841 rectum adenocarcinoma 9.7
842 post-traumatic stress disorder 9.7
843 thrombocytosis 9.7
844 kernicterus 9.7
845 contact dermatitis 9.7
846 endometriosis 9.7
847 food allergy 9.7
848 rhabdomyosarcoma 9.7
849 thymoma 9.7
850 bone inflammation disease 9.7
851 carotid artery disease 9.7
852 cellulitis 9.7
853 thyroid gland medullary carcinoma 9.7
854 multidrug-resistant tuberculosis 9.7
855 pancreatic adenocarcinoma 9.7
856 dyslexia 9.7
857 macular retinal edema 9.7
858 avian influenza 9.7
859 hypokalemia 9.7
860 familial retinoblastoma 9.7
861 pancreatitis 9.7
862 human immunodeficiency virus infectious disease 9.7
863 prion disease 9.7
864 spondylitis 9.7
865 malignant pleural mesothelioma 9.7
866 parathyroid adenoma 9.7
867 ileus 9.7
868 fascioliasis 9.7
869 skin melanoma 9.7
870 autosomal dominant polycystic kidney disease 9.7
871 fasciitis 9.7
872 substance dependence 9.7
873 sickle cell disease 9.7
874 spastic paraplegia 4 9.7
875 biliary tract cancer 9.7
876 bronchopulmonary dysplasia 9.7
877 granulocytopenia 9.7
878 polymyositis 9.7
879 pudendal neuralgia 9.7
880 bunion 9.7
881 cerebral atrophy 9.7
882 differentiated thyroid carcinoma 9.7
883 benign idiopathic neonatal seizures 9.7
884 obsolete: combined hyperlipidemia 9.7
885 beryllium disease 9.6 HLA-DRB1 HLA-DQB1 HLA-DQA1 HLA-DPA1
886 rheumatic heart disease 9.6 IL10 HLA-DRB1 HLA-DQA1 HLA-B
887 apnea, obstructive sleep 9.6
888 machado-joseph disease 9.6
889 alopecia, androgenetic, 1 9.6
890 chiari malformation type i 9.6
891 dentatorubral-pallidoluysian atrophy 9.6
892 erythroleukemia, familial 9.6
893 hernia, hiatus 9.6
894 ige responsiveness, atopic 9.6
895 intussusception 9.6
896 keratitis, hereditary 9.6
897 marfan syndrome 9.6
898 medulloblastoma 9.6
899 melanoma, uveal 9.6
900 otitis media 9.6
901 exfoliation syndrome 9.6
902 sarcoidosis 1 9.6
903 spondylolisthesis 9.6
904 thrombocytopenia 2 9.6
905 thyroid cancer, nonmedullary, 1 9.6
906 tracheoesophageal fistula with or without esophageal atresia 9.6
907 wolff-parkinson-white syndrome 9.6
908 acrocallosal syndrome 9.6
909 alexander disease 9.6
910 chordoma 9.6
911 galactorrhea 9.6
912 moyamoya disease 1 9.6
913 myelofibrosis 9.6
914 pancreatic agenesis 1 9.6
915 retinitis pigmentosa 9.6
916 tardive dyskinesia 9.6
917 uruguay faciocardiomusculoskeletal syndrome 9.6
918 oncocytoma 9.6
919 adenomyosis 9.6
920 suppression of tumorigenicity 12 9.6
921 astigmatism 9.6
922 microvascular complications of diabetes 1 9.6
923 ascaris lumbricoides infection 9.6
924 reflex sympathetic dystrophy 9.6
925 late-onset retinal degeneration 9.6
926 meningioma, radiation-induced 9.6
927 gastrointestinal stromal tumor 9.6
928 spermatogenic failure 3 9.6
929 meningioma, familial 9.6
930 resting heart rate, variation in 9.6
931 ovarian cancer 1 9.6
932 ovarian hyperstimulation syndrome 9.6
933 kala-azar 1 9.6
934 hypertension, diastolic 9.6
935 microphthalmia, syndromic 10 9.6
936 kawasaki disease 9.6
937 acute promyelocytic leukemia 9.6
938 microvascular complications of diabetes 2 9.6
939 pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis 9.6
940 hearing loss, noise-induced 9.6
941 aortic valve disease 2 9.6
942 alacrima, achalasia, and mental retardation syndrome 9.6
943 immunodeficiency, common variable, 10 9.6
944 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.6
945 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.6
946 hypertrophic scars 9.6
947 invasive aspergillosis 9.6
948 fetal alcohol syndrome 9.6
949 fetal alcohol spectrum disorder 9.6
950 autosomal recessive disease 9.6
951 paraganglioma 9.6
952 androgenic alopecia 9.6
953 atrioventricular block 9.6
954 diabetic encephalopathy 9.6
955 colorectal adenocarcinoma 9.6
956 hepatocellular adenoma 9.6
957 anosognosia 9.6
958 generalized epilepsy with febrile seizures plus 9.6
959 glucocorticoid-induced osteoporosis 9.6
960 pollen allergy 9.6
961 bone disease 9.6
962 childhood acute lymphocytic leukemia 9.6
963 adenoid cystic carcinoma 9.6
964 non-alcoholic steatohepatitis 9.6
965 hypogonadotropic hypogonadism 9.6
966 osteonecrosis 9.6
967 pneumoconiosis 9.6
968 anthracosis 9.6
969 suppression amblyopia 9.6
970 amblyopia 9.6
971 esophageal atresia 9.6
972 microinvasive gastric cancer 9.6
973 short bowel syndrome 9.6
974 portal hypertension 9.6
975 ovarian disease 9.6
976 pulpitis 9.6
977 arteriovenous malformation 9.6
978 schizophreniform disorder 9.6
979 pneumocystosis 9.6
980 spinal meningioma 9.6
981 hemopericardium 9.6
982 autonomic neuropathy 9.6
983 penile cancer 9.6
984 portal vein thrombosis 9.6
985 emery-dreifuss muscular dystrophy 9.6
986 lyme disease 9.6
987 iron deficiency anemia 9.6
988 pericardial effusion 9.6
989 protein-energy malnutrition 9.6
990 nephrotic syndrome 9.6
991 denture stomatitis 9.6
992 cryptococcosis 9.6
993 male infertility 9.6
994 leiomyoma 9.6
995 telangiectasis 9.6
996 hypercementosis 9.6
997 focal segmental glomerulosclerosis 9.6
998 hellp syndrome 9.6
999 background diabetic retinopathy 9.6
1000 cholestasis 9.6
1001 obstructive jaundice 9.6
1002 dental fluorosis 9.6
1003 peptic esophagitis 9.6
1004 algoneurodystrophy 9.6
1005 anus cancer 9.6
1006 frozen shoulder 9.6
1007 sclerosing cholangitis 9.6
1008 acute cholangitis 9.6
1009 autosomal dominant cerebellar ataxia 9.6
1010 angioedema 9.6
1011 neuroendocrine carcinoma 9.6
1012 hypogonadism 9.6
1013 hyperostosis 9.6
1014 enamel erosion 9.6
1015 extratemporal epilepsy 9.6
1016 larynx cancer 9.6
1017 pancreas disease 9.6
1018 chondroma 9.6
1019 glycogen storage disease 9.6
1020 nonspecific interstitial pneumonia 9.6
1021 acquired polycythemia 9.6
1022 bronchiolitis 9.6
1023 iga glomerulonephritis 9.6
1024 allergic contact dermatitis 9.6
1025 ascaridiasis 9.6
1026 oligodendroglioma 9.6
1027 teratoma 9.6
1028 liposarcoma 9.6
1029 histiocytosis 9.6
1030 breast adenocarcinoma 9.6
1031 choriocarcinoma 9.6
1032 retinitis 9.6
1033 wheat allergy 9.6
1034 olfactory neuroblastoma 9.6
1035 anovulation 9.6
1036 lynch syndrome 9.6
1037 acute myocarditis 9.6
1038 thyroid gland papillary carcinoma 9.6
1039 mouth disease 9.6
1040 myofascial pain syndrome 9.6
1041 ebola hemorrhagic fever 9.6
1042 hepatitis e 9.6
1043 chromophobe renal cell carcinoma 9.6
1044 secretory meningioma 9.6
1045 lymphoplasmacyte-rich meningioma 9.6
1046 bile duct cancer 9.6
1047 uremia 9.6
1048 essential tremor 9.6
1049 arteriolosclerosis 9.6
1050 aortic disease 9.6
1051 intestinal disease 9.6
1052 silent myocardial infarction 9.6
1053 progressive multifocal leukoencephalopathy 9.6
1054 inherited metabolic disorder 9.6
1055 juvenile rheumatoid arthritis 9.6
1056 hypogonadotropism 9.6
1057 diverticulitis 9.6
1058 cocaine abuse 9.6
1059 septic arthritis 9.6
1060 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.6
1061 oropharynx cancer 9.6
1062 tongue cancer 9.6
1063 perinatal necrotizing enterocolitis 9.6
1064 degenerative disc disease 9.6
1065 diabetic macular edema 9.6
1066 central sleep apnea 9.6
1067 homocystinuria 9.6
1068 cleft lip 9.6
1069 keratoconjunctivitis 9.6
1070 postpartum depression 9.6
1071 pulmonary emphysema 9.6
1072 drug dependence 9.6
1073 cocaine dependence 9.6
1074 hemophilia 9.6
1075 ankrd26-related thrombocytopenia 9.6
1076 genetic prion diseases 9.6
1077 al amyloidosis 9.6
1078 anaplastic oligoastrocytoma 9.6
1079 chiari malformation 9.6
1080 chronic inflammatory demyelinating polyneuropathy 9.6
1081 chronic thromboembolic pulmonary hypertension 9.6
1082 congenital rubella 9.6
1083 dentinogenesis imperfecta type 2 9.6
1084 enchondroma 9.6
1085 microscopic polyangiitis 9.6
1086 splenomegaly 9.6
1087 stevens-johnson syndrome/toxic epidermal necrolysis 9.6
1088 sudden sensorineural hearing loss 9.6
1089 transposition of the great arteries 9.6
1090 true thymic hyperplasia 9.6
1091 color vision deficiency 9.6
1092 hypoxia 9.6
1093 obsolete: atypical teratoid/rhabdoid tumor 9.6
1094 malignant tumor of penis 9.6
1095 lysosomal disease 9.6
1096 dementia pugilistica 9.6
1097 autoimmune disease of peripheral nervous system 9.5 MOG MBP HCRT
1098 secondary progressive multiple sclerosis 9.5 MBP IL10
1099 autoimmune optic neuritis 9.5 MOG MBP IL10 AQP4
1100 primary progressive multiple sclerosis 9.5 MOG MBP IL10 HLA-DRB1
1101 immune system disease 9.5 MOG MBP IL10 AQP4
1102 alacrima, congenital, autosomal dominant 9.4
1103 total anomalous pulmonary venous return 1 9.4
1104 aortic valve disease 1 9.4
1105 blue rubber bleb nevus 9.4
1106 caffey disease 9.4
1107 carcinoid tumors, intestinal 9.4
1108 cleft palate, isolated 9.4
1109 cone-rod dystrophy 2 9.4
1110 cornea plana 1, autosomal dominant 9.4
1111 craniofacial-deafness-hand syndrome 9.4
1112 major affective disorder 1 9.4
1113 dystonia, dopa-responsive 9.4
1114 factor viii deficiency 9.4
1115 floating-harbor syndrome 9.4
1116 gilles de la tourette syndrome 9.4
1117 hepatic adenomas, familial 9.4
1118 diaphragmatic hernia, congenital 9.4
1119 huntington disease 9.4
1120 hyperlipoproteinemia, type v 9.4
1121 hypogonadotropic hypogonadism 7 with or without anosmia 9.4
1122 multiple system atrophy 1 9.4
1123 inclusion body myositis 9.4
1124 lentigines 9.4
1125 macular dystrophy, vitelliform, 2 9.4
1126 mesothelioma, malignant 9.4
1127 motion sickness 9.4
1128 facioscapulohumeral muscular dystrophy 1 9.4
1129 facioscapulohumeral muscular dystrophy 2 9.4
1130 night blindness, congenital stationary, autosomal dominant 2 9.4
1131 nephrolithiasis, calcium oxalate 9.4
1132 pernicious anemia 9.4
1133 platelet membrane fluidity 9.4
1134 polykaryocytosis inducer 9.4
1135 familial adenomatous polyposis 1 9.4
1136 protoporphyria, erythropoietic, 1 9.4
1137 dowling-degos disease 1 9.4
1138 silver-russell syndrome 9.4
1139 emery-dreifuss muscular dystrophy 2, autosomal dominant 9.4
1140 spastic paraplegia 3, autosomal dominant 9.4
1141 stiff-person syndrome 9.4
1142 chromosome 2q35 duplication syndrome 9.4
1143 syringomyelia, noncommunicating isolated 9.4
1144 tarsal coalition 9.4
1145 temporal arteritis 9.4
1146 testicular torsion 9.4
1147 tetralogy of fallot 9.4
1148 thrombophilia due to activated protein c resistance 9.4
1149 trigeminal neuralgia 9.4
1150 tuberous sclerosis 1 9.4
1151 vesicoureteral reflux 1 9.4
1152 vitreoretinopathy, neovascular inflammatory 9.4
1153 wilms tumor 1 9.4
1154 acrodermatitis enteropathica, zinc-deficiency type 9.4
1155 acyl-coa dehydrogenase, short-chain, deficiency of 9.4
1156 adrenocortical carcinoma, hereditary 9.4
1157 anencephaly 9.4
1158 anus, imperforate 9.4
1159 australia antigen 9.4
1160 sitosterolemia 9.4
1161 chediak-higashi syndrome 9.4
1162 charge syndrome 9.4
1163 plasminogen deficiency, type i 9.4
1164 fraser syndrome 1 9.4
1165 factor x deficiency 9.4
1166 glycogen storage disease ii 9.4
1167 hemochromatosis, type 1 9.4
1168 hydrocephalus, congenital, 1 9.4
1169 richards-rundle syndrome 9.4
1170 plasmodium falciparum blood infection level 9.4
1171 maple syrup urine disease 9.4
1172 metachromatic leukodystrophy 9.4
1173 mucopolysaccharidosis, type iiic 9.4
1174 myasthenia gravis 9.4
1175 mycosis fungoides 9.4
1176 epilepsy, myoclonic juvenile 9.4
1177 3-methylglutaconic aciduria, type iii 9.4
1178 nonarteritic anterior ischemic optic neuropathy 9.4
1179 osteoid osteoma 9.4
1180 pseudoxanthoma elasticum 9.4
1181 enhanced s-cone syndrome 9.4
1182 tay-sachs disease 9.4
1183 alopecia, congenital 9.4
1184 x inactivation, familial skewed, 1 9.4
1185 fabry disease 9.4
1186 hemophilia a 9.4
1187 congenital hemidysplasia with ichthyosiform erythroderma and limb defects 9.4
1188 premature ovarian failure 1 9.4
1189 tarp syndrome 9.4
1190 retinitis pigmentosa-deafness syndrome 9.4
1191 fatal familial insomnia 9.4
1192 short tarsus with absence of lower eyelashes 9.4
1193 epilepsy, idiopathic generalized 9.4
1194 fryns microphthalmia syndrome 9.4
1195 budd-chiari syndrome 9.4
1196 patent ductus venosus 9.4
1197 cataract 3, multiple types 9.4
1198 wilms tumor 5 9.4
1199 trichothiodystrophy 1, photosensitive 9.4
1200 xanthomatosis 9.4
1201 schizophrenia 2 9.4
1202 bosma arhinia microphthalmia syndrome 9.4
1203 hemophagocytic lymphohistiocytosis, familial, 2 9.4
1204 polydactyly 9.4
1205 intervertebral disc disease 9.4
1206 alpha-thalassemia 9.4
1207 chudley-mccullough syndrome 9.4
1208 epilepsy, familial focal, with variable foci 1 9.4
1209 progressive familial heart block, type ib 9.4
1210 orthostatic intolerance 9.4
1211 huntington disease-like 3 9.4
1212 langerhans cell histiocytosis 9.4
1213 north american indian childhood cirrhosis 9.4
1214 abdominal obesity-metabolic syndrome 1 9.4
1215 atrioventricular septal defect 9.4
1216 huntington disease-like 2 9.4
1217 glaucoma, normal tension 9.4
1218 alzheimer disease 4 9.4
1219 creatinine clearance quantitative trait locus 9.4
1220 angioid streaks 9.4
1221 spastic paraplegia 7, autosomal recessive 9.4
1222 mammographic density 9.4
1223 patent ductus arteriosus 1 9.4
1224 parathyroid carcinoma 9.4
1225 severe cutaneous adverse reaction 9.4
1226 granulomatosis with polyangiitis 9.4
1227 aplastic anemia 9.4
1228 pseudohyperkalemia, familial, 2, due to red cell leak 9.4
1229 hyperinsulinemic hypoglycemia, familial, 5 9.4
1230 hyperinsulinemic hypoglycemia, familial, 4 9.4
1231 immunodeficiency 25 9.4
1232 preterm premature rupture of the membranes 9.4
1233 asthma-related traits 4 9.4
1234 alzheimer disease 12 9.4
1235 thrombocytopenia 4 9.4
1236 ewing sarcoma 9.4
1237 diabetes mellitus, ketosis-prone 9.4
1238 chromosome 2p16.1-p15 deletion syndrome 9.4
1239 pancreatic cancer 3 9.4
1240 myxoid liposarcoma 9.4
1241 ectodermal dysplasia-syndactyly syndrome 2 9.4
1242 cholangitis, primary sclerosing 9.4
1243 cyanosis, transient neonatal 9.4
1244 fanconi anemia, complementation group l 9.4
1245 hypertelorism, preauricular sinus, punctal pits, and deafness 9.4
1246 microcephaly, epilepsy, and diabetes syndrome 9.4
1247 rigidity and multifocal seizure syndrome, lethal neonatal 9.4
1248 hemorrhage, intracerebral 9.4
1249 diarrhea 6 9.4
1250 periodic fever, menstrual cycle-dependent 9.4
1251 membranous nephropathy 9.4
1252 prostate cancer, hereditary, 2 9.4
1253 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.4
1254 leptin deficiency or dysfunction 9.4
1255 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.4
1256 pulmonary hypertension, primary, 3 9.4
1257 hyperprolactinemia 9.4
1258 pachyonychia congenita 3 9.4
1259 carbonic anhydrase va deficiency, hyperammonemia due to 9.4
1260 neu-laxova syndrome 2 9.4
1261 sideroblastic anemia with b-cell immunodeficiency, periodic fevers, and developmental delay 9.4
1262 cardiac conduction disease with or without dilated cardiomyopathy 9.4
1263 chops syndrome 9.4
1264 ring chromosome 14 syndrome 9.4
1265 lymphatic malformation 7 9.4
1266 mulchandani-bhoj-conlin syndrome 9.4
1267 actn3 deficiency 9.4
1268 alkuraya-kucinskas syndrome 9.4
1269 hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome 9.4
1270 neurodevelopmental disorder with cerebellar atrophy and with or without seizures 9.4
1271 fetal akinesia deformation sequence 2 9.4
1272 chronic ulcer of skin 9.4
1273 chronic diarrhea due to guanylate cyclase 2c overactivity 9.4
1274 stargardt disease 9.4
1275 adrenal cortical carcinoma 9.4
1276 keshan disease 9.4
1277 hemophagocytic lymphohistiocytosis 9.4
1278 tick-borne encephalitis 9.4
1279 erythema multiforme 9.4
1280 lambert-eaton myasthenic syndrome 9.4
1281 congenital hypothyroidism 9.4
1282 arrhythmogenic right ventricular cardiomyopathy 9.4
1283 usher syndrome 9.4
1284 hyperphosphatemia 9.4
1285 visceral heterotaxy 9.4
1286 distal arthrogryposis 9.4
1287 alcohol-related birth defect 9.4
1288 chorioamnionitis 9.4
1289 vitamin b12 deficiency 9.4
1290 zollinger-ellison syndrome 9.4
1291 cone dystrophy 9.4
1292 tricuspid valve disease 9.4
1293 hemorrhagic cystitis 9.4
1294 tongue squamous cell carcinoma 9.4
1295 large cell neuroendocrine carcinoma 9.4
1296 colon adenoma 9.4
1297 writing disorder 9.4
1298 progesterone-receptor positive breast cancer 9.4
1299 alexithymia 9.4
1300 lymphocytic colitis 9.4
1301 ptosis 9.4
1302 umbilical hernia 9.4
1303 drug allergy 9.4
1304 salmonellosis 9.4
1305 physical disorder 9.4
1306 acromesomelic dysplasia 9.4
1307 myoglobinuria 9.4
1308 lymphoblastic lymphoma 9.4
1309 hepatic veno-occlusive disease 9.4
1310 chronic myelomonocytic leukemia 9.4
1311 superior semicircular canal dehiscence 9.4
1312 cakut 9.4
1313 alzheimer's disease 1 9.4
1314 endometrial hyperplasia 9.4
1315 lung non-squamous non-small cell carcinoma 9.4
1316 thyroid gland anaplastic carcinoma 9.4
1317 migraine with aura 9.4
1318 pelvic inflammatory disease 9.4
1319 asymptomatic neurosyphilis 9.4
1320 endometrial disease 9.4
1321 cysticercosis 9.4
1322 sleeping sickness 9.4
1323 trypanosomiasis 9.4
1324 cerebral artery occlusion 9.4
1325 venous insufficiency 9.4
1326 xerophthalmia 9.4
1327 cholelithiasis 9.4
1328 dermatomyositis 9.4
1329 monocular esotropia 9.4
1330 asbestosis 9.4
1331 dentin caries 9.4
1332 osteomalacia 9.4
1333 mild pre-eclampsia 9.4
1334 lactose intolerance 9.4
1335 interstitial nephritis 9.4
1336 juvenile glaucoma 9.4
1337 mastitis 9.4
1338 filariasis 9.4
1339 gastric ulcer 9.4
1340 hand, foot and mouth disease 9.4
1341 lepromatous leprosy 9.4
1342 hypospadias 9.4
1343 borderline personality disorder 9.4
1344 meconium aspiration syndrome 9.4
1345 placenta praevia 9.4
1346 brucellosis 9.4
1347 leech infestation 9.4
1348 esophageal varix 9.4
1349 allergic conjunctivitis 9.4
1350 orbital cellulitis 9.4
1351 anemia of prematurity 9.4
1352 disseminated intravascular coagulation 9.4
1353 gingival recession 9.4
1354 epidural abscess 9.4
1355 alternating exotropia 9.4
1356 exotropia 9.4
1357 cardiac tamponade 9.4
1358 suppurative otitis media 9.4
1359 hypertensive heart disease 9.4
1360 hypertensive retinopathy 9.4
1361 hyperandrogenism 9.4
1362 choledocholithiasis 9.4
1363 hepatorenal syndrome 9.4
1364 coronary thrombosis 9.4
1365 tibial neuropathy 9.4
1366 gastroparesis 9.4
1367 hemosiderosis 9.4
1368 pica disease 9.4
1369 filarial elephantiasis 9.4
1370 anisometropia 9.4
1371 varicocele 9.4
1372 retroperitoneal sarcoma 9.4
1373 shigellosis 9.4
1374 vulva cancer 9.4
1375 pancytopenia 9.4
1376 secondary hyperparathyroidism 9.4
1377 hemolytic-uremic syndrome 9.4
1378 dyscalculia 9.4
1379 nephrocalcinosis 9.4
1380 acoustic neuroma 9.4
1381 hereditary hemorrhagic telangiectasia 9.4
1382 cerebral atherosclerosis 9.4
1383 migraine without aura 9.4
1384 keratoconjunctivitis sicca 9.4
1385 shipyard eye 9.4
1386 balanitis 9.4
1387 renal osteodystrophy 9.4
1388 paronychia 9.4
1389 right bundle branch block 9.4
1390 klebsiella pneumonia 9.4
1391 urethritis 9.4
1392 coccidioidomycosis 9.4
1393 scleritis 9.4
1394 tuberous sclerosis 9.4
1395 kwashiorkor 9.4
1396 biliary atresia 9.4
1397 campylobacteriosis 9.4
1398 beriberi 9.4
1399 hepatic infarction 9.4
1400 opisthorchiasis 9.4
1401 pharyngoconjunctival fever 9.4
1402 amenorrhea 9.4
1403 bipolar i disorder 9.4
1404 tracheal calcification 9.4
1405 chronic purulent otitis media 9.4
1406 adult-onset still's disease 9.4
1407 pulmonary valve insufficiency 9.4
1408 patellofemoral pain syndrome 9.4
1409 dumping syndrome 9.4
1410 olivopontocerebellar atrophy 9.4
1411 leber congenital amaurosis 9.4
1412 personality disorder 9.4
1413 panniculitis 9.4
1414 pleural disease 9.4
1415 dermatomycosis 9.4
1416 ectropion 9.4
1417 renovascular hypertension 9.4
1418 keratosis 9.4
1419 skeletal tuberculosis 9.4
1420 ventricular septal defect 9.4
1421 neovascular glaucoma 9.4
1422 endocrine gland cancer 9.4
1423 richter's syndrome 9.4
1424 vascular cancer 9.4
1425 mitral valve stenosis 9.4
1426 thyroid gland cancer 9.4
1427 pericarditis 9.4
1428 peritoneal mesothelioma 9.4
1429 calcinosis 9.4
1430 cannabis dependence 9.4
1431 atrial heart septal defect 9.4
1432 viral hepatitis 9.4
1433 hyperuricemia 9.4
1434 leiomyosarcoma 9.4
1435 thymus lipoma 9.4
1436 exostosis 9.4
1437 hepatitis d 9.4
1438 autoimmune hepatitis 9.4
1439 heel spur 9.4
1440 enamel caries 9.4
1441 essential thrombocythemia 9.4
1442 myeloproliferative neoplasm 9.4
1443 vulvovaginitis 9.4
1444 hidradenitis suppurativa 9.4
1445 hidradenitis 9.4
1446 arteriosclerosis 9.4
1447 macrocytic anemia 9.4
1448 renal artery disease 9.4
1449 protein s deficiency 9.4
1450 retinal vascular disease 9.4
1451 motor peripheral neuropathy 9.4
1452 angiodysplasia 9.4
1453 tooth erosion 9.4
1454 orchitis 9.4
1455 testicular disease 9.4
1456 relapsing polychondritis 9.4
1457 chondromalacia 9.4
1458 ovarian brenner tumor 9.4
1459 dermoid cyst 9.4
1460 cystic teratoma 9.4
1461 transitional cell carcinoma 9.4
1462 ossifying fibromyxoid tumor 9.4
1463 myoma 9.4
1464 acrodermatitis 9.4
1465 cerebellar disease 9.4
1466 hemoglobin c disease 9.4
1467 hemoglobinopathy 9.4
1468 glucosephosphate dehydrogenase deficiency 9.4
1469 aleutian mink disease 9.4
1470 cockayne syndrome 9.4
1471 bursitis 9.4
1472 cystic kidney disease 9.4
1473 carbohydrate metabolic disorder 9.4
1474 antiphospholipid syndrome 9.4
1475 acinar cell carcinoma 9.4
1476 churg-strauss syndrome 9.4
1477 astrocytoma 9.4
1478 malignant glioma 9.4
1479 grade iii astrocytoma 9.4
1480 early myoclonic encephalopathy 9.4
1481 cystic lymphangioma 9.4
1482 interstitial lung disease 9.4
1483 gingival overgrowth 9.4
1484 papillary carcinoma 9.4
1485 gallbladder cancer 9.4
1486 neurilemmoma 9.4
1487 syringomyelia 9.4
1488 embryonal carcinoma 9.4
1489 gm2 gangliosidosis 9.4
1490 localized osteosarcoma 9.4
1491 bacterial vaginosis 9.4
1492 breast disease 9.4
1493 mastocytosis 9.4
1494 gallbladder adenocarcinoma 9.4
1495 lung benign neoplasm 9.4
1496 plexopathy 9.4
1497 plasmacytoma 9.4
1498 protein c deficiency 9.4
1499 leukorrhea 9.4
1500 thrombophlebitis 9.4
1501 placental insufficiency 9.4
1502 insulinoma 9.4
1503 adrenal cortical adenocarcinoma 9.4
1504 merkel cell carcinoma 9.4
1505 angioma serpiginosum 9.4
1506 malignant ovarian brenner tumor 9.4
1507 pyoderma 9.4
1508 coronary restenosis 9.4
1509 gait apraxia 9.4
1510 milk allergy 9.4
1511 large cell carcinoma 9.4
1512 intraocular retinoblastoma 9.4
1513 prostate disease 9.4
1514 atrophic rhinitis 9.4
1515 placenta accreta 9.4
1516 adenocarcinoma in situ 9.4
1517 gastroesophageal junction adenocarcinoma 9.4
1518 mixed glioma 9.4
1519 ovarian cyst 9.4
1520 hemangioblastoma 9.4
1521 blepharospasm 9.4
1522 pulmonary coin lesion 9.4
1523 lung adenoma 9.4
1524 lice infestation 9.4
1525 mature teratoma 9.4
1526 malignant syringoma 9.4
1527 gastrinoma 9.4
1528 acute pyelonephritis 9.4
1529 large intestine cancer 9.4
1530 retinal disease 9.4
1531 well-differentiated liposarcoma 9.4
1532 pleomorphic liposarcoma 9.4
1533 cerebral lymphoma 9.4
1534 inferior myocardial infarction 9.4
1535 mitral valve disease 9.4
1536 overnutrition 9.4
1537 diffuse idiopathic skeletal hyperostosis 9.4
1538 hepatoblastoma 9.4
1539 pseudosarcomatous fibromatosis 9.4
1540 carotid artery occlusion 9.4
1541 mediastinitis 9.4
1542 scabies 9.4
1543 afferent loop syndrome 9.4
1544 brachial plexus lesion 9.4
1545 intestinal volvulus 9.4
1546 pellagra 9.4
1547 actinomycosis 9.4
1548 polyhydramnios 9.4
1549 night blindness 9.4
1550 chronic fatigue syndrome 9.4
1551 pyoderma gangrenosum 9.4
1552 oral cavity cancer 9.4
1553 decubitus ulcer 9.4
1554 bacterial pneumonia 9.4
1555 parasitic helminthiasis infectious disease 9.4
1556 metagonimiasis 9.4
1557 rosacea 9.4
1558 chorioretinitis 9.4
1559 sideroblastic anemia 9.4
1560 cutaneous leishmaniasis 9.4
1561 mucocutaneous leishmaniasis 9.4
1562 pemphigus 9.4
1563 scotoma 9.4
1564 carotid artery dissection 9.4
1565 cannabis abuse 9.4
1566 smoldering myeloma 9.4
1567 bronchiectasis 9.4
1568 dextrocardia 9.4
1569 plantar fasciitis 9.4
1570 necrotizing fasciitis 9.4
1571 babesiosis 9.4
1572 tenosynovitis 9.4
1573 biliary tract disease 9.4
1574 diabetic neuropathy 9.4
1575 hemorrhoid 9.4
1576 xanthogranulomatous cholecystitis 9.4
1577 diastolic heart failure 9.4
1578 irritable bowel syndrome 9.4
1579 polyarteritis nodosa 9.4
1580 neonatal abstinence syndrome 9.4
1581 refractive error 9.4
1582 esotropia 9.4
1583 congenital syphilis 9.4
1584 hydrocele 9.4
1585 developmental coordination disorder 9.4
1586 hypoplastic left heart syndrome 9.4
1587 periostitis 9.4
1588 heterotaxy 9.4
1589 keloid disorder 9.4
1590 microcephaly 9.4
1591 dysferlinopathy 9.4
1592 dystrophinopathies 9.4
1593 isolated gonadotropin-releasing hormone deficiency 9.4
1594 prothrombin-related thrombophilia 9.4
1595 suclg1-related mitochondrial dna depletion syndrome, encephalomyopathic form with methylmalonic aciduria 9.4
1596 trichorhinophalangeal syndrome 9.4
1597 12q14 microdeletion syndrome 9.4
1598 allergic angiitis 9.4
1599 amaurosis fugax 9.4
1600 anaplastic oligodendroglioma 9.4
1601 aneurysm of sinus of valsalva 9.4
1602 aortic arch interruption 9.4
1603 auditory neuropathy spectrum disorder 9.4
1604 bk-virus nephropathy 9.4
1605 brain tumor, childhood 9.4
1606 candida glabrata 9.4
1607 carcinoma showing thymus-like differentiation 9.4
1608 central serous chorioretinopathy 9.4
1609 cerebrospinal fluid leak 9.4
1610 cerulean cataract 9.4
1611 collagenopathy type 2 alpha 1 9.4
1612 congenital contractures 9.4
1613 congenital torticollis 9.4
1614 cor triatriatum 9.4
1615 diencephalic syndrome 9.4
1616 diphallia 9.4
1617 disseminated infection with mycobacterium avium complex 9.4
1618 distomatosis 9.4
1619 double discordia 9.4
1620 doxorubicin induced cardiomyopathy 9.4
1621 dysfibrinogenemia 9.4
1622 encephalocele 9.4
1623 enteropathica 9.4
1624 exfoliative dermatitis 9.4
1625 familial colorectal cancer 9.4
1626 familial hypertension 9.4
1627 fetal and neonatal alloimmune thrombocytopenia 9.4
1628 fetal macrosomia 9.4
1629 fibromatosis 9.4
1630 gangliosidosis 9.4
1631 growth hormone deficiency 9.4
1632 heavy metal poisoning 9.4
1633 heparin-induced thrombocytopenia 9.4
1634 homologous wasting disease 9.4
1635 hyperacusis 9.4
1636 logopenic progressive aphasia 9.4
1637 meralgia paresthetica 9.4
1638 multifocal motor neuropathy 9.4
1639 mycobacterium fortuitum 9.4
1640 mycobacterium marinum 9.4
1641 neisseria meningitidis infection 9.4
1642 neonatal meningitis 9.4
1643 neurosyphilis 9.4
1644 pediatric ulcerative colitis 9.4
1645 periodontal ehlers-danlos syndrome 9.4
1646 precocious puberty 9.4
1647 primary biliary cholangitis 9.4
1648 primary orthostatic hypotension 9.4
1649 primary orthostatic tremor 9.4
1650 prosthetic joint infection 9.4
1651 pulmonary artery agenesis 9.4
1652 pyogenic granuloma 9.4
1653 reversible cerebral vasoconstriction syndrome 9.4
1654 single ventricular heart 9.4
1655 sirenomelia 9.4
1656 spondylarthropathy 9.4
1657 st anthony's fire 9.4
1658 syndrome of inappropriate antidiuretic hormone 9.4
1659 systemic onset juvenile idiopathic arthritis 9.4
1660 trypanosomiasis, human east-african 9.4
1661 tuberculous meningitis 9.4
1662 wallerian degeneration 9.4
1663 stargardt macular degeneration 9.4
1664 trnt1 deficiency 9.4
1665 abdominal wall defect 9.4
1666 age-related hearing loss 9.4
1667 congenital plasminogen deficiency 9.4
1668 core binding factor acute myeloid leukemia 9.4
1669 opioid addiction 9.4
1670 autonomic dysfunction 9.4
1671 cerebral aneurysms 9.4
1672 developmental dyspraxia 9.4
1673 febrile seizures 9.4
1674 persistent vegetative state 9.4
1675 pituitary tumors 9.4
1676 malignant peritoneal mesothelioma 9.4
1677 refractory anemia with excess blasts in transformation 9.4
1678 b-cell non-hodgkin lymphoma 9.4
1679 cleft lip/palate 9.4
1680 asbestos intoxication 9.4
1681 genetic hypertension 9.4
1682 inflammatory myopathy with abundant macrophages 9.4
1683 angiocentric glioma 9.4
1684 uniparental disomy of chromosome 7 9.4
1685 isolated focal cortical dysplasia type ib 9.4
1686 isolated focal cortical dysplasia type ia 9.4
1687 isolated focal cortical dysplasia type i 9.4
1688 qualitative or quantitative defects of dystrophin 9.4
1689 qualitative or quantitative defects of dysferlin 9.4
1690 rare hereditary hemochromatosis 9.4
1691 acute pandysautonomia 9.4
1692 ring chromosome 9.4
1693 lmna-related cardiocutaneous progeria syndrome 9.4
1694 rare odontogenic tumor 9.4
1695 acyl-coa dehydrogenase deficiency 9.4
1696 avascular necrosis 9.4
1697 malignant epithelial tumor of ovary 9.4
1698 lethal neonatal spasticity-epileptic encephalopathy syndrome 9.4
1699 secondary sclerosing cholangitis 9.4
1700 erythema multiforme major 9.4
1701 ethylene glycol poisoning 9.4
1702 congenital amyoplasia 9.4
1703 argyria 9.4
1704 rasopathy 9.4
1705 anterior cutaneous nerve entrapment syndrome 9.4
1706 serotonin syndrome 9.4
1707 acute liver failure 9.4
1708 lymphedema 9.4
1709 premature aging 9.4
1710 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.4
1711 maternal uniparental disomy 9.4
1712 rare tumor 9.4
1713 cleft mitral valve 9.4
1714 thrombotic microangiopathy 9.4
1715 overgrowth syndrome 9.4
1716 right aortic arch 9.4
1717 refractory anemia 9.4
1718 congenital alacrima 9.4
1719 vitreoretinopathy 9.4
1720 primary adrenal insufficiency 9.4
1721 precursor t-cell acute lymphoblastic leukemia 9.4
1722 narcolepsy 1 9.4 MOG HLA-DRB1 HLA-DQB1 HCRT
1723 vogt-koyanagi-harada disease 9.4 IL10 HLA-DRB1 HLA-DQB1 HLA-DQA1 HLA-B
1724 autoimmune disease of central nervous system 9.0 MOG MBP IL10 HLA-DRB1 AQP4

Graphical network of the top 20 diseases related to Acute Disseminated Encephalomyelitis:



Diseases related to Acute Disseminated Encephalomyelitis

Symptoms & Phenotypes for Acute Disseminated Encephalomyelitis

Drugs & Therapeutics for Acute Disseminated Encephalomyelitis

Drugs for Acute Disseminated Encephalomyelitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 36, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Antibodies, Blocking Phase 4
2 Vaccines Phase 4
3
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
4
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
5
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
6
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
7
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
8 Hormone Antagonists Phase 3
9 Hormones Phase 3
10 Antiemetics Phase 3
11 Neuroprotective Agents Phase 3
12 Gastrointestinal Agents Phase 3
13 Anti-Inflammatory Agents Phase 3
14 Methylprednisolone Acetate Phase 3
15 Peripheral Nervous System Agents Phase 3
16 glucocorticoids Phase 3
17 Prednisolone acetate Phase 3
18 Autonomic Agents Phase 3
19 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3
20
rituximab Approved Phase 2 174722-31-7 10201696
21 Antibodies Phase 2
22 Immunoglobulins Phase 2
23 Immunologic Factors Phase 2
24 Antineoplastic Agents, Immunological Phase 2
25 Antirheumatic Agents Phase 2
26 Protective Agents
27 Adjuvants, Immunologic
28 Anti-Infective Agents
29 Radiation-Protective Agents
30 Anti-Bacterial Agents
31 Antibiotics, Antitubercular
32 interferons
33 Interferon Inducers
34 Antiviral Agents
35 polysaccharide-K
36 Autoantibodies

Interventional clinical trials:

(showing 12, show less)
# Name Status NCT ID Phase Drugs
1 Neutralizing Antibody Titers 6 Years After the Third Dose of Inactivated Japanese Encephalitis Vaccine and Projected Duration of Protection Completed NCT02039440 Phase 4
2 Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone Unknown status NCT00004645 Phase 3
3 Randomized Clinical Trial of Plasma Exchanges Versus Sham Plasma Exchanges in Disabling Multiple Sclerosis Acute Relapses Refractory to Steroid Treatment Completed NCT01442233 Phase 3
4 Prospective Assessment of Efficacy of Immunoadsorption Therapy in Managing Childhood NMDA-Receptor (NMDAR) Antibodies Encephalitis Not yet recruiting NCT03274375 Phase 2 IA session;Rituximab
5 Pediatric Multiple Sclerosis in Egypt. A Multi-center Registry of 186 Patients Completed NCT03360188
6 A Phase IV Study to Assess the Safety of Menveo Vaccine Being Used by HMO Subjects Aged 11-21 Years of Age Completed NCT01452464
7 A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil Recruiting NCT03087136
8 Epidemiology and Prognosis of Encephalitis in Intensive Care Recruiting NCT02906631
9 Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases Active, not recruiting NCT00445367
10 PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes. Not yet recruiting NCT03942952
11 Management of Acute Disseminated Encephalomyelitis in Neurology Unit of Assiut University Children Hospital Not yet recruiting NCT03284801
12 Observational Prospective Multicentered Study Evaluating Initial Clinical Presentation of Inflammatory Optic Neuritis (ON) Associated or Not With Autoantibodies Anti- Myelin-oligodendrocyte-glycoprotein (MOG-Ab) Not yet recruiting NCT03345537

Search NIH Clinical Center for Acute Disseminated Encephalomyelitis

Genetic Tests for Acute Disseminated Encephalomyelitis

Anatomical Context for Acute Disseminated Encephalomyelitis

MalaCards organs/tissues related to Acute Disseminated Encephalomyelitis:

41
Brain, Spinal Cord, Eye, T Cells, Bone, Bone Marrow, B Cells

Publications for Acute Disseminated Encephalomyelitis

Articles related to Acute Disseminated Encephalomyelitis:

(showing 1587, show less)
# Title Authors PMID Year
1
Doxycycline in autoimmune central nervous system disorders in children: an in vitro study. 9 38
17990580 2007
2
Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis. 9 38
15519122 2004
3
Structural similarity between the bee venom peptides and the immunodominant human myelin basic proteins: role for pathogenesis of acute disseminated encephalomyelitis. 9 38
12589368 2003
4
A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid. 9 38
12269735 2002
5
Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease. 9 38
7936289 1994
6
MOG antibody seropositive aseptic meningitis: A new clinical phenotype. 38
31108402 2019
7
Neurosyphilis in the modern era: Literature review and case series. 38
31427238 2019
8
An Uncommon Diagnosis in a Child Presenting With Double Vision and Imbalance. 38
31335784 2019
9
Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study. 38
31276927 2019
10
Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes. 38
31383792 2019
11
Acute ataxia in children: Common causes and yield of diagnostic work-up in the era of varicella vaccination. 38
31327588 2019
12
A unique case of multiphasic ADEM or what else? 38
31351264 2019
13
A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children. 38
31319355 2019
14
Myelin in the Central Nervous System: Structure, Function, and Pathology. 38
31066630 2019
15
Acute disseminated encephalomyelitis following varicella-zoster virus infection: Case report of effective treated both in clinical symptom and neuroimaging. 38
31342665 2019
16
Callosal lesions on magnetic resonance imaging with multiple sclerosis, neuromyelitis optica spectrum disorder and acute disseminated encephalomyelitis. 38
31030018 2019
17
Acute Disseminated Encephalomyelitis in Children: An Updated Review Based on Current Diagnostic Criteria. 38
31371120 2019
18
Diagnostic Considerations in Acute Disseminated Encephalomyelitis and the Interface with MOG Antibody. 38
31340401 2019
19
Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US. 38
31295724 2019
20
A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion. 38
30933712 2019
21
Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China. 38
30049802 2019
22
Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes. 38
31212763 2019
23
The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders. 38
31276911 2019
24
Differential Diagnosis of Pediatric Multiple Sclerosis. 38
31163654 2019
25
Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. 38
30076494 2019
26
Acute Hemorrhagic Leukoencephalopathy: Pathological Features and Cerebrospinal Fluid Cytokine Profiles. 38
31376926 2019
27
Clinical time course of pediatric acute disseminated encephalomyelitis. 38
30833092 2019
28
Low bone marrow signal on T1-weighted magnetic resonance imaging in a 2-year-old patient with acute disseminated encephalomyelitis. 38
31242538 2019
29
Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome. 38
30844860 2019
30
A Nationwide Survey of Pediatric-onset Japanese Encephalitis in Japan. 38
30252025 2019
31
Acute Disseminated Encephalomyelitis After Chikungunya Infection. 38
30830174 2019
32
The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. 38
31094288 2019
33
Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder. 38
30825703 2019
34
Retinal haemorrhage in a child with optic neuritis and acute disseminated encephalomyelitis. 38
31061175 2019
35
Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: A cohort study in China. 38
30904690 2019
36
Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children. 38
30221764 2019
37
Acute disseminated encephalomyelitis due to abrus precatorius poisoning - A case report. 38
31249468 2019
38
Ratio of Alpha 2-Macroglobulin Levels in Cerebrospinal Fluid and Serum: An Expression of Neuroinflammation in Acute Disseminated Encephalomyelitis. 38
31248670 2019
39
New onset transverse myelitis diagnostic accuracy and patient experiences. 38
30738277 2019
40
Acute disseminated encephalomyelitis due to JC virus infection as the onset of non-Hodgkin's lymphoma. 38
30337110 2019
41
Inflammatory demyelinating diseases of the central nervous system in Niger. 38
30270137 2019
42
Fulminant acute disseminated encephalomyelitis in children. 38
30522797 2019
43
Clinical Presentation and outcome of acute disseminated encephalomyelitis in Saudi Arabia. Tertiary Center Experience. 38
31056539 2019
44
Spectrum of neurological complications in chikungunya fever: experience at a tertiary care centre and review of literature. 38
30678544 2019
45
Early Recognition and Treatment of Acute Disseminated Encephalomyelitis in Pediatrics: A Case Series. 38
30973501 2019
46
Delayed appearance of transient hyperintensity foci on T1-weighted magnetic resonance imaging in acute disseminated encephalomyelitis. 38
30671706 2019
47
[Acute disseminated encephalomyelitis due to Mycoplasma pneumoniae in a previously healthy boy]. 38
30236414 2019
48
Brain MRI Findings in Pediatric-Onset Neuromyelitis Optica Spectrum Disorder: Challenges in Differentiation from Acute Disseminated Encephalomyelitis. 38
30846436 2019
49
Acute disseminated encephalomyelitis in an older adult following prostate resection. 38
30619950 2019
50
Acute disseminated encephalomyelitis, a rare post-malaria neurological complication: Case report and review of the literature. 38
29574241 2019
51
Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. 38
30575890 2019
52
[Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis]. 38
30841683 2019
53
A multicenter comparison of MOG-IgG cell-based assays. 38
30728305 2019
54
Atypical Presentation of Acute Disseminated Encephalomyelitis (ADEM) in a Middle-Aged Adult. 38
30886135 2019
55
SUCCESSFUL TREATMENT OF ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM) BY PROMPT USAGE OF IMMUNOGLOBULINS - CASE REPORT AND REVIEW OF THE LITERATURE. 38
31363340 2019
56
Temporal Trends of Pediatric Hospitalizations with Acute Disseminated Encephalomyelitis in the United States: An Analysis from 2006 to 2014 using National Inpatient Sample. 38
30528761 2019
57
Zika virus found in brain tissue of a multiple sclerosis patient undergoing an acute disseminated encephalomyelitis-like episode. 38
30226115 2019
58
MOG antibody-associated encephalomyelitis/encephalitis. 38
30907249 2019
59
[Negative anti-myelin oligodendrocyte glycoprotein antibodies in a boy with acquired demyelinating syndrome in the CNS]. 38
30864543 2019
60
Real-world validation of the 2017 McDonald criteria for pediatric MS. 38
30697581 2019
61
Acute Disseminated Encephalomyelitis (ADEM) and Increased Intracranial Pressure Associated With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies. 38
31248672 2019
62
[Clinical features of children with acute disseminated encephalomyelitis and related recurrence factors]. 38
30907344 2019
63
Vaccination-associated acute disseminated encephalomyelitis. 38
30683508 2019
64
Myelin oligodendrocyte glycoprotein antibodies in neurological disease. 38
30559466 2019
65
A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child. 38
30590238 2019
66
Adenovirus-Associated Central Nervous System Disease in Children. 38
30413311 2019
67
[Vaccination Controversies: An Adult Case of Post-Vaccinal Acute Disseminated Encephalomyelitis]. 38
30753808 2019
68
Acute Disseminated Encephalomyelitis in an Incarcerated Adolescent Presents as Acute Psychosis: Case Report and Literature Review. 38
27749808 2019
69
Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases. 38
30592992 2019
70
Acute disseminated encephalomyelitis in children - clinical and MRI decision making in the emergency department. 38
30846211 2019
71
Early predictors of epilepsy and subsequent relapse in children with acute disseminated encephalomyelitis. 38
30730236 2019
72
Increased Intracranial Pressure in Acute Disseminated Encephalomyelitis. 38
30477374 2019
73
A Rare Case of Adult Acute Disseminated Encephalomyelitis Associated with Primary Epstein-Barr Virus Infection. 38
31139588 2019
74
An interesting case of acute disseminated encephalomyelitis following E. coli infection. 38
30911524 2019
75
Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations. 38
30300850 2019
76
Application of Plasma Exchange in Steroid-Responsive Encephalopathy. 38
30873174 2019
77
Causal relationship between immunological responses and adverse reactions following vaccination. 38
30503656 2019
78
Pure Red Cell Aplasia (PRCA) and Cerebellar Hypoplasia as Atypical Features of Polyglandular Autoimmune Syndrome Type I (APS-1): Two Sisters With the Same AIRE Mutation but Different Phenotypes. 38
30863741 2019
79
[Diagnostic value of antibodies to myelin oligodendrocyte glycoprotein in demyelinating diseases of the central nervous system]. 38
31156236 2019
80
[Clinical characteristics and diagnosis of disseminated encephalomyelitis in adults]. 38
31156239 2019
81
Genomic Analyses of Acute Flaccid Myelitis Cases among a Cluster in Arizona Provide Further Evidence of Enterovirus D68 Role. 38
30670612 2019
82
A Longitudinally Extensive Spinal Cord Lesion Restricted to Gray Matter in an Adolescent Male. 38
30949125 2019
83
Gray variant of acute disseminated encephalomyelitis and its response to immunomodulatory drugs. 38
30860138 2019
84
Diagnosis and Management of Acute Encephalitis in Children. 38
30232787 2019
85
[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing]. 38
30264269 2018
86
Factors Related to Long Term Motor, Behavioral, and Scholastic Outcome in Children with Acute Disseminated Encephalomyelitis. 38
30409457 2018
87
Identifying a new subtype of multiple sclerosis. 38
30215581 2018
88
Acute disseminated encephalomyelitis: complication of a vaccine preventable disease. 38
30593525 2018
89
Oculomotor Nerve Palsy After Influenza Vaccine in Inflammatory Bowel Disease. 38
30820379 2018
90
Concurrent Guillain-Barré syndrome, transverse myelitis and encephalitis post-Zika: A case report and review of the pathogenic role of multiple arboviral immunity. 38
30292020 2018
91
Acute disseminated encephalomyelitis: A rare autoimmune complication of herpes simplex encephalitis in the adult. 38
30336448 2018
92
Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders. 38
30212767 2018
93
Viral Encephalitis. 38
30366550 2018
94
In-Hospital Pediatric Stroke Alert Activation. 38
30318284 2018
95
Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania. 38
30284401 2018
96
Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. 38
30055153 2018
97
How should we diagnose acute disseminated encephalomyelitis? 38
29926479 2018
98
Recurrent disseminated encephalomyelitis: A case report and literature review. 38
30241037 2018
99
Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders. 38
30014148 2018
100
Implications of the International Paediatric Multiple Sclerosis Study Group consensus criteria for paediatric acute disseminated encephalomyelitis: a nationwide validation study. 38
29744874 2018
101
Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders. 38
30075406 2018
102
Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies. 38
30382857 2018
103
Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein. 38
30365980 2018
104
Human parechovirus type 6 and Guillain-Barré syndrome: a case report. 38
29995288 2018
105
Post-malaria neurological syndrome: four cases, review of the literature and clarification of the nosological framework. 38
30367650 2018
106
Adult-onset hemophagocytic lymphohistiocytosis type 2 presenting as a demyelinating disease. 38
30053752 2018
107
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder. 38
30048919 2018
108
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients. 38
30054790 2018
109
Pediatric Multiple Sclerosis: an Update. 38
30229541 2018
110
Posterior Reversible Encephalopathy Syndrome in a Patient with Variegate Porphyria: A Case Report. 38
30483456 2018
111
Fatal acute disseminated encephalomyelitis (ADEM) after third ventricle colloid cyst resection with ultrasonic aspirator during neuroendoscopic procedure. 38
30058026 2018
112
Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes. 38
29468668 2018
113
Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated With Gray Matter Predominant Transverse Myelitis Mimicking Acute Flaccid Myelitis: A Presentation of Two Cases. 38
30077551 2018
114
Teaching Case 5-2018: Integrated morphological and immunological work-up of neurosurgical specimen allows accurate diagnosis of neuroinflammatory lesions: an example of acute disseminated encephalomyelitis (ADEM) associated with anti-MOG antibodies. 38
30103853 2018
115
Rituximab was effective for acute disseminated encephalomyelitis followed by recurrent optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies. 38
29661590 2018
116
Relapsing acute disseminated encephalomyelitis followed by optic neuritis in children; a clinical entity associated with anti-MOG antibody. 38